February 28, 2020 / 9:41 PM / a month ago

BRIEF-Cellular Biomedicine Says Cannot Accurately Predict Impact From Coronavirus

Feb 28 (Reuters) - Cellular Biomedicine Group Inc:

* CELLULAR BIOMEDICINE GROUP ANNOUNCES Q4 AND FULL YEAR 2019 FINANCIAL RESULTS AND RECENT OPERATIONAL PROGRESS

* CELLULAR BIOMEDICINE - FULL EXTENT TO WHICH CORONAVIRUS WILL NEGATIVELY IMPACT BUSINESS & RESULTS IS HIGHLY UNCERTAIN & CANNOT BE ACCURATELY PREDICTED

* CELLULAR BIOMEDICINE GROUP SAYS CO HAS EXPERIENCED, & EXPECT TO CONTINUE TO EXPERIENCE, A SLOWDOWN IN PATIENT RECRUITMENT FOR CLINICAL STUDIES

* CELLULAR BIOMEDICINE GROUP SAYS CO IS MINDFUL OF ONGOING RISKS POSED BY CORONAVIRUS DISEASE, OR COVID-19 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below